DNP (DNP Select Income Fund Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by DNP officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-24 | Corebridge Financial, Inc. | — | J | — | — |
| 2026-07-24 | MetLife Investment Management, LLC | 10%+ Owner | J | — | — |
| 2026-02-12 | Mark G. Kahrer | Director | Buy | — | — |
| 2025-02-20 | GERALDINE M MCNAMARA | Director | Sell | — | — |
| 2024-11-27 | David D Grumhaus Jr. | President and CEO | Buy | — | — |
| 2024-08-16 | MetLife Investment Management, LLC | 10%+ Owner | Buy | — | — |
| 2024-07-31 | Corebridge Financial, Inc. | — | Sell | — | — |
| 2024-07-24 | MetLife Investment Management, LLC | 10%+ Owner | Buy | — | — |
| 2024-07-09 | Philip R McLoughlin | Director | Buy | — | — |
| 2024-06-21 | DANIEL PETRISKO | Executive Vice President | Buy | — | — |
| 2024-06-14 | Kyle P. West | — | Buy | — | — |
| 2024-06-11 | AMERICAN INTERNATIONAL GROUP, INC. | — | J | — | — |
| 2024-06-05 | Connie M Luecke | VP & Chief Investment Officer | Buy | — | — |
| 2023-12-21 | DANIEL PETRISKO | Executive Vice President | Buy | — | — |
| 2023-12-14 | David D Grumhaus Jr. | President and CEO | Buy | — | — |
| 2023-12-12 | Connie M Luecke | VP & Chief Investment Officer | Buy | — | — |
| 2023-12-11 | Kyle P. West | — | Buy | — | — |
| 2023-10-04 | Connie M Luecke | VP & Chief Investment Officer | Buy | — | — |
| 2023-10-03 | Kyle P. West | — | Buy | — | — |
| 2023-07-26 | AMERICAN INTERNATIONAL GROUP, INC. | — | J | — | — |
| 2023-07-25 | MetLife Investment Management, LLC | 10%+ Owner | J | — | — |
| 2023-07-13 | MetLife Investment Management, LLC | 10%+ Owner | J | — | — |
| 2023-06-20 | Connie M Luecke | VP & Chief Investment Officer | Buy | — | — |
| 2023-04-28 | Mareile B. Cusack | Director | Buy | — | — |
| 2022-10-07 | Kyle P. West | — | Buy | — | — |
| 2022-05-13 | Kyle P. West | — | Buy | — | — |
| 2022-05-04 | Connie M Luecke | VP & Chief Investment Officer | Buy | — | — |
| 2021-10-05 | DAVID J VITALE | Director | Buy | — | — |
| 2021-08-05 | David D Grumhaus Jr. | President* | Buy | — | — |
| 2021-06-01 | Kyle P. West | — | Buy | — | — |
| 2021-05-05 | Connie M Luecke | VP & Chief Investment Officer | Buy | — | — |
| 2021-04-06 | DAVID J VITALE | Director | Buy | — | — |
| 2021-03-16 | EILEEN A MORAN | Director | J | — | — |
| 2021-03-10 | ROBERT J GENETSKI | Director | J | — | — |
| 2021-03-10 | DANIEL PETRISKO | Executive Vice President | J | — | — |
| 2021-03-10 | DONALD C BURKE | Director | J | — | — |
| 2021-03-10 | GERALDINE M MCNAMARA | Director | J | — | — |
| 2021-03-10 | Philip R McLoughlin | Director | J | — | — |
| 2020-09-23 | Kyle P. West | — | Buy | — | — |
| 2020-04-06 | Connie M Luecke | VP & Chief Investment Officer | Buy | — | — |
| 2020-04-03 | Kyle P. West | — | Buy | — | — |
| 2020-03-02 | ROBERT J GENETSKI | Director | Buy | — | — |
| 2019-06-24 | Connie M Luecke | VP & Chief Investment Officer | Buy | — | — |
| 2019-03-01 | AMERICAN INTERNATIONAL GROUP INC | — | J | — | — |
| 2019-01-30 | AMERICAN INTERNATIONAL GROUP INC | — | Buy | — | — |
| 2019-01-03 | DAVID J VITALE | Director | Buy | — | — |
| 2018-02-02 | Clifford W. Hoffman Jr. | Director | Buy | — | — |
| 2017-12-22 | Connie M Luecke | — | Buy | — | — |
| 2017-10-04 | Philip R McLoughlin | Director | Sell | — | — |
| 2016-12-01 | Clifford W. Hoffman Jr. | Director | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 95,602 | — |
| — | Director | 71,155 | — |
| — | Director | 58,515 | — |
| — | Director | 45,000 | — |
| — | President and CEO | 44,186 | — |
| — | Director | 37,457 | — |
| — | — | 28,971 | — |
| — | Director | 28,281 | — |
| — | Director | 23,000 | — |
| — | VP & Chief Investment Officer | 19,149 | — |
| — | Director | 18,317 | — |
| — | Director | 15,397 | — |
| — | Director | 13,534 | — |
| — | President and CEO | 8,361 | — |
| — | — | 7,176 | — |
| — | Director | 6,783 | — |
| — | Director | 6,750 | — |
| — | Director | 5,344 | — |
| — | Treasurer and CFO | 5,251 | — |
| — | Director | 4,752 | — |
| — | Senior VP and Secretary | 4,175 | — |
| — | Executive Vice President | 3,569 | — |
| — | — | 675 | — |
| — | — | 660 | — |
| — | 10%+ Owner | 467 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the DNP quote page; the site-wide leaderboard is on the insider transactions hub.